1. Inhibition of Atherosclerosis by Angiotensin II Type 1 Receptor Antagonists

   • Stefan Peters

   Current Opinion 23 April 2013 Pages: 221 - 224

2. Low-Density Lipoprotein Cholesterol: How Low Can We Go?

   • Daniel P. Sherbet
   • Puja Garg
   • Subhash Banerjee

   Review Article 23 April 2013 Pages: 225 - 232

3. Antiplatelet and Anticoagulant Therapy for Atherothrombotic Disease: The Role of Current and Emerging Agents

   • Dominick J. Angiolillo
   • José Luis Ferreiro

   Review Article 24 April 2013 Pages: 233 - 250

   

4. Contemporary Drug Treatment of Infective Endocarditis

   • Marwa A. Sabe
   • Nabin K. Shrestha
   • Venu Menon

   Therapy in Practice 03 May 2013 Pages: 251 - 258

5. Bridging Therapy: A Challenging Area in the Management of Patients with Atrial Fibrillation

   • Yutao Guo
   • Gregory Y. H. Lip
   • Stavros Apostolakis

   Commentary 26 June 2013 Pages: 259 - 261

6. Adherence and Persistence with Prasugrel Following Acute Coronary Syndrome with Percutaneous Coronary Intervention

   • Beth L. Nordstrom
   • Jason C. Simeone
   • Mark B. Effron

   Original Research Article 22 May 2013 Pages: 263 - 271

   

7. Clinical Outcomes, Health Resource Use, and Cost in Patients with Early versus Late Dual or Triple Anti-Platelet Treatment for Acute Coronary Syndrome

   • Howard Friedman
   • Patrick Mollon
   • Prakash Navaratnam

   Original Research Article 01 June 2013 Pages: 273 - 283

   

8. Lomitapide: A Review of its Use in Adults with Homozygous Familial Hypercholesterolemia

   • Caroline M. Perry

   Adis Drug Evaluation 30 May 2013 Pages: 285 - 296

   

9. 62^nd Annual Scientific Sessions of the American College of Cardiology: 9–11 March 2013; San Francisco, CA, USA

   • Amitabh Prakash

   Meeting Report 03 July 2013 Pages: 297 - 300